Last updated: 2026-10-13 19:58:20. Prices reflect the latest regular market data. Stock price data is sourced from Massive.
Cellebrite DI Ltd (CLBT) operates in the -- sector and is listed on NASDAQ. The stock is currently priced at $11.43, with a market capitalization of $2.83B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $9.58 to $19.98. This page covers its latest market performance, valuation, price trends and company information.
$2.83B | |
$11.47 | |
$26.30 | |
$3.80 | |
$11.44 | |
1.95M | |
2.98M | |
-- | |
$19.98 | |
$9.58 | |
-- | |
-- |
Cellebrite DI Ltd (CLBT) is currently trading at $11.43 as of 2026-10-13 19:42:23, down 0.13% ($0.01) from the previous close of $11.44
During today's regular trading session, CLBT has traded between $3.80 and $26.30, with a trading volume of 1.95M shares. The current price is near the middle of today's range.
Over the past seven days, Cellebrite DI Ltd (CLBT) moved from $11.07 to $11.43, representing a gain of 3.21% ($0.36).
The stock traded between $10.97 and $11.60 during the period. The latest price is near the upper end of the 7-day range, indicating moderate upward.
The average daily volume was 1.78 million shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 17.7%
CLBT is currently trading at $11.43, placing it 17.7% of the way from its 52-week low of $9.58 to its 52-week high of $19.98. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Cellebrite DI Ltd provides AI-powered digital investigative and intelligence solutions that help public and private sector customers transform investigative workflows, make digital data more accessible and actionable, and improve the efficiency of mobile research and application security. Its solutions support law enforcement, defense, and intelligence agencies in advancing investigations, border security, counterterrorism, intelligence operations, and cyber operations. The company's software also enables enterprises and service providers to collect and review data for corporate investigations, eDiscovery, incident response, and mobile application validation. It operates in the Americas, APAC, and EMEA, with the majority of revenue from the Americas.
| Employees | 1285 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Cellebrite DI Ltd (CLBT) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.